C
Causaly
Biotech & Life Sciences · London, United Kingdom · Founded 2018
AI research platform for life sciences R&D MoreLess
Causaly builds an agentic AI research platform for life sciences R&D. It helps drug discovery and clinical development teams find and interpret biomedical evidence, turning research questions into cited, reviewable answers.
The platform combines a biomedical knowledge graph of cause-and-effect links between targets, diseases and drugs, scientific information retrieval, and a data fabric that joins public literature, full-text journals and a customer's internal data. Products include Agentic Research, Scientific Workflows, Bio Graph and its API, and Pipeline Graph. Causaly is also available inside Microsoft 365 Copilot.
Customers are pharmaceutical and biotechnology companies, such as Eisai and Innate Pharma, that use it for target identification, biomarker discovery, disease biology and indication expansion. Causaly sells enterprise software subscriptions, supported by its in-house scientists.
keywords: AI drug discovery, knowledge graph, agentic AI, life sciences R&D, target identification, biomarker discovery, SaaS
Talent graph
Causaly's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Causaly has talent and traffic
team presence
across markets
Market sentiment
What the market is saying about Causaly
An AI-synthesized read of the highest-engagement posts about Causaly on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Causaly on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.